Abstract: The server includes a communication unit that acquires, by communication, information related to a performance in power control of electrified vehicle. In addition, the server includes a processor (control unit) that performs control to provide a privilege related to the communication service to the user of electrified vehicle based on the acquired information related to the track record.

Abstract: A server includes a determination unit that determines a state of congestion at an EVSE unit by a plurality of electrified vehicles responding to a request for execution of electric power control, and a setting unit that sets an incentive for each of the electrified vehicles to perform the electric power control at another EVSE unit when the determination unit determines that congestion is occurring at the EVSE unit.

Abstract: When an operation for reserving a rental car is performed on a communication terminal, reservation information is transmitted from the communication terminal to the management server. The management server extracts a reservation period included in the reservation information, issues an incentive based on the reservation period, and notifies the incentive. When the user applies an incentive to the communication device to confirm the reservation, the operation information is sent to the management server, and the management server confirms the reservation. When the reservation confirmation is notified, the communication terminal sets the reservation period as VPP participation period of the electrified vehicles, and transmits the participation information including the information of VPP participation period to HEMS controllers. HEMS controllers register the electrified vehicles as power resources in the period specified by VPP participation period.

Abstract: The invention provides a chroman derivative represented by the following Formula (I) that enables the production of an SMTP compound having a desired structure: wherein, in Formula (I), each of Y1 and Y2 independently represents a hydrogen atom, a hydroxy group, an alkoxy group, an aryloxy group, or a halogen atom; each of R1 and R2 independently represents a hydrogen atom, an alkyl group, an aryl group, an acyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, or a carbamoyl group; L represents an aliphatic hydrocarbon group having from 4 to 10 carbon atoms; each X independently represents a hydroxy group or a carboxy group; and n represents an integer from 0 to 2.

Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.

Abstract: The invention provides a chroman derivative represented by the following Formula (I) that enables the production of an SMTP compound having a desired structure: wherein, in Formula (I), each of Y1 and Y2 independently represents a hydrogen atom, a hydroxy group, an alkoxy group, an aryloxy group, or a halogen atom; each of R1 and R2 independently represents a hydrogen atom, an alkyl group, an aryl group, an acyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, or a carbamoyl group; L represents an aliphatic hydrocarbon group having from 4 to 10 carbon atoms; each X independently represents a hydroxy group or a carboxy group; and n represents an integer from 0 to 2.

Abstract: A triprenyl phenol compound represented by the following formula (II) and (III) and having a thrombolysis-enhancing activity, and an efficient method for producing the triprenyl phenol compound. In formula (II) and (III), R1 represents an aromatic group having as a substituent or as a part of a substituent at least one member selected from the group consisting of a carboxyl group, a hydroxyl group, a sulfonic acid group and a secondary amino group, or an aromatic group which comprises a secondary amino group and may comprise nitrogen; R4 in the general formula (III) represents an aromatic amino acid residue represented by the general formula (III-1) below; X represents —CHY—(CH3)2Z; and Y and Z are respectively —H or —OH or together form a single bond: (III-1) wherein R5 represents a hydroxyl group which may be present or absent; and n represents an integer of 0 or 1.

Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.

Abstract: A triprenyl phenol compound represented by the following formula (II) and (III) and having a thrombolysis-enhancing activity, and an efficient method for producing the triprenyl phenol compound. In formula (II) and (III), R1 represents an aromatic group having as a substituent or as a part of a substituent at least one member selected from the group consisting of a carboxyl group, a hydroxyl group, a sulfonic acid group and a secondary amino group, or an aromatic group which comprises a secondary amino group and may comprise nitrogen; R4 in the general formula (III) represents an aromatic amino acid residue represented by the general formula (III-1) below; X represents —CHY—(CH3)2Z; and Y and Z are respectively —H or —OH or together form a single bond: (III-1) wherein R5 represents a hydroxyl group which may be present or absent; and n represents an integer of 0 or 1.

Abstract: The present invention provides a triprenyl phenol compound represented by the following formula (II) and (III) and having a thrombolysis-enhancing activity, and an efficient method for producing the triprenyl phenol compound. In formula (II) and (III), R1 represents an aromatic group having as a substituent or as a part of a substituent at least one member selected from the group consisting of a carboxyl group, a hydroxyl group, a sulfonic acid group and a secondary amino group, or an aromatic group which comprises a secondary amino group and may comprise nitrogen; R4 in the general formula (III) represents an aromatic amino acid residue represented by the general formula (III-1) below; X represents —CHY—(CH3)2Z; and Y and Z are respectively —H or —OH or together form a single bond: (III-1) wherein R5 represents a hydroxyl group which may be present or absent; and n represents an integer of 0 or 1.

Abstract: When the engine being in an idling operation and it is in a running state (S410, S420), a value 1 is set to a learning-determination flag F1 (step S460) and the learning of the idling control value is performed when the transmission is in the state of Lo gear and it is not immediately after a Hi-Lo shifting has been performed (S430 to S450).

Abstract: In a hybrid vehicle 20, when a deceleration demand based on accelerator-off is made in selecting an S position that allows arbitrary selection of shift positions SP1 to SP6, and fuel cut cannot be prohibited from a state of a battery 50, an engine 22 and motors MG1 and MG2 are controlled so that a driving force based on a torque demand Tr* is outputted with the fuel cut (Steps S410, S420, S360 to S400). When the deceleration demand based on the accelerator-off is made in selecting the S position, and the fuel cut can be prohibited from the state of the battery 50, the engine 22 and the motors MG1 and MG2 are controlled so that the engine 22 substantially performs self-sustaining operation at a target rotation speed Ne0 and a driving force based on the torque demand Tr* is outputted (Steps S340 to S400).

Abstract: In an engine 5 including an in-cylinder injector, the valve timing of an intake valve is retarded by VVT (Variable Valve Timing) controlled by an engine ECU to decompress in a combustion chamber at engine startup. In accordance with a configuration in which the valve timing of intake valve is advanced in a stepped manner from an initial set value, fuel injection from in-cylinder injector is inhibited during the time when the advance is equal to or below a predetermined standard value, and fuel injection from in-cylinder injector is allowed when exceeding the predetermined standard value, whereby degradation in the exhaust emission level in accordance with start time decompression control can be suppressed.

Abstract: The technique of the invention determines whether input data for driving and controlling a cooling fan have any abnormality (steps S100 and S110), sets an actual drive level F* of the cooling fan to a high level (Hi) in the event of detection of any abnormality (step S130), and controls a fan motor to drive the cooling fan at the set drive level F* (step S140). This arrangement effectively prevents a temperature rise to an abnormally high level in any of an engine and motors even in the event of any abnormality arising in the input data.

Abstract: The present invention provides a triprenyl phenol compound represented by the following formula (II) and (III) and having a thrombolysis-enhancing activity, and an efficient method for producing the triprenyl phenol compound. In formula (II) and (III), R1 represents an aromatic group having as a substituent or as a part of a substituent at least one member selected from the group consisting of a carboxyl group, a hydroxyl group, a sulfonic acid group and a secondary amino group, or an aromatic group which comprises a secondary amino group and may comprise nitrogen; R4 in the general formula (III) represents an aromatic amino acid residue represented by the general formula (III-1) below; X represents —CHY—(CH3)2Z; and Y and Z are respectively —H or —OH or together form a single bond: (III-1) wherein R5 represents a hydroxyl group which may be present or absent; and n represents an integer of 0 or 1.

Abstract: In a hybrid vehicle 20, when a deceleration demand based on accelerator-off is made in selecting an S position that allows arbitrary selection of shift positions SP1 to SP6, and fuel cut cannot be prohibited from a state of a battery 50, an engine 22 and motors MG1 and MG2 are controlled so that a driving force based on a torque demand Tr* is outputted with the fuel cut (Steps S410, S420, S360 to S400). When the deceleration demand based on the accelerator-off is made in selecting the S position, and the fuel cut can be prohibited from the state of the battery 50, the engine 22 and the motors MG1 and MG2 are controlled so that the engine 22 substantially performs self-sustaining operation at a target rotation speed Ne0 and a driving force based on the torque demand Tr* is outputted (Steps S340 to S400).

Abstract: When the engine being in an idling operation and it is in a running state (S410, S420), a value 1 is set to a learning-determination flag F1 (step S460) and the learning of the idling control value is performed when the transmission is in the state of Lo gear and it is not immediately after a Hi-Lo shifting has been performed (S430 to S450).

Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.

Abstract: Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.